Betuvax-CoV-2

· Artgen Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Betuvax-CoV-2, covering 2022-03-08 to 2022-03-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Immunogenicity of Recombinant COVID-19 Vaccine Betuvax-CoV-2 [Phase 1, Phase 2]